Cheryl Pace

发表

Mefloquine for preventing malaria during travel to endemic areas

N. Maayan, M. Tickell-Painter, R. Saunders, 2017, The Cochrane database of systematic reviews.

Working towards consensus on methods used to elicit participant-reported safety data in uncomplicated malaria clinical drug studies: a Delphi technique study

K. Barnes, Clare I. R. Chandler, E. Allen, 2017, Malaria Journal.

Neuroauditory Toxicity of Artemisinin Combination Therapies—Have Safety Concerns Been Addressed?

D. Terlouw, D. Lalloo, Cheryl Pace, 2014, The American journal of tropical medicine and hygiene.

Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study

E. Vittinghoff, Joelle M. Brown, A. Stergachis, 2016, Malaria Journal.

Menstrual cups and cash transfer to reduce sexual and reproductive harm and school dropout in adolescent schoolgirls: study protocol of a cluster-randomised controlled trial in western Kenya

Duolao Wang, P. Phillips-Howard, Jane K. A. Juma, 2019, BMC Public Health.

Scheduled Intermittent Screening with Rapid Diagnostic Tests and Treatment with Dihydroartemisinin-Piperaquine versus Intermittent Preventive Therapy with Sulfadoxine-Pyrimethamine for Malaria in Pregnancy in Malawi: An Open-Label Randomized Controlled Trial

Steve M. Taylor, Duolao Wang, S. Meshnick, 2016, PLoS medicine.

Perceptions and utilization of the anti-malarials artemether-lumefantrine and dihydroartemisinin-piperaquine in young children in the Chikhwawa District of Malawi: a mixed methods study

D. Terlouw, D. Lalloo, R. Tolhurst, 2015, Malaria Journal.

Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data

K. Barnes, Clare I. R. Chandler, U. Mehta, 2013, Malaria Journal.

Efficacy and safety of intermittent preventive treatment and intermittent screening and treatment versus single screening and treatment with dihydroartemisinin–piperaquine for the control of malaria in pregnancy in Indonesia: a cluster-randomised, open-label, superiority trial

R. Price, Duolao Wang, R. Ahmed, 2019, The Lancet. Infectious diseases.

Development of a pharmacovigilance safety monitoring tool for the rollout of single low-dose primaquine and artemether-lumefantrine to treat Plasmodium falciparum infections in Swaziland: a pilot study

E. Vittinghoff, A. Stergachis, Joelle M Brown, 2016, Malaria Journal.

Evaluating harm associated with anti-malarial drugs: a survey of methods used by clinical researchers to elicit, assess and record participant-reported adverse events and related data

K. Barnes, Clare I. R. Chandler, U. Mehta, 2013, Malaria Journal.